ARCHIVES

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

NIH Financial Plan Slated For Discussion At Dec. 18 Meeting

December 14, 1990

Gene Therapy Experiments Get RDAC Okay

August 10, 1990

ODAC Oks Melphalan Injection WR-2721 Needs More Data

February 7, 1992

NCI-Approved Clinical Trials

June 25, 2004

Bush Proposes $27.9 Billion for NIH, Plus $1.4B Reprogram From FY03

February 7, 2003

Mesothelioma Survival, QOL Improved With Alimta, Platinol

March 28, 2003